GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genvec Inc (FRA:GVC2) » Definitions » Other Current Receivables

Genvec (FRA:GVC2) Other Current Receivables : €0.00 Mil (As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Genvec Other Current Receivables?

Genvec's Other Current Receivables for the quarter that ended in Mar. 2017 was €0.00 Mil.


Genvec Other Current Receivables Historical Data

The historical data trend for Genvec's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genvec Other Current Receivables Chart

Genvec Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genvec Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genvec Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Genvec Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Genvec's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Genvec (FRA:GVC2) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Genvec Inc was incorporated under the laws of the state of Delaware on December 7, 1992.The Company is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. Its development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus or RSV, herpes simplex virus or HSV, and malaria. In the area of animal health the Company is developing vaccines against foot-and-mouth disease or FMD. In collaboration with Novartis, the Companys hearing and balance disorders program is focused on the restoration of hearing and balance function through the regeneration of critical cells of the inner ear. The Company is currently developing preventative vaccines, against RSV and malaria and therapeutic vaccine against HSV.

Genvec (FRA:GVC2) Headlines

No Headlines